Oncology Clinic Note Template

Subjective:
Synopsis:
The patient presents for follow-up of post-treatment neurological symptoms and recovery monitoring. The patient reports recurrence of previous symptoms, including fatigue, numbness in the fingers, and unsteadiness during ambulation. The patient was evaluated by a neurologist last week, who performed a comprehensive neurological examination and ordered magnetic resonance imaging and nerve conduction studies to assess for potential new pathology. The neurologist indicated that the current symptoms may represent residual effects of prior oncologic treatment but sought to exclude new developments. The patient denies any new or worsening symptoms beyond those described. There is no report of new lesions or tumor recurrence based on recent imaging. The patient has not restarted any medications since the last visit and has not received additional chemotherapy or radiation therapy. The patient is currently under surveillance with a focus on symptom management and functional recovery.

History of Present Illness:
The patient presents for follow-up of post-treatment neurological symptoms and recovery monitoring. The patient reports recurrence of previous symptoms, including fatigue, numbness in the fingers, and unsteadiness during ambulation. The patient was evaluated by a neurologist last week, who performed a comprehensive neurological examination and ordered magnetic resonance imaging and nerve conduction studies to assess for potential new pathology. The neurologist indicated that the current symptoms may represent residual effects of prior oncologic treatment but sought to exclude new developments. The patient denies any new or worsening symptoms beyond those described. There is no report of new lesions or tumor recurrence based on recent imaging. The patient has not restarted any medications since the last visit and has not received additional chemotherapy or radiation therapy. The patient is currently under surveillance with a focus on symptom management and functional recovery.

Objective:
Lab Results:
Recent laboratory evaluation demonstrates recovering hematologic parameters following chemotherapy. Inflammatory markers are mildly elevated. No other laboratory abnormalities are noted.

Diagnostics:
Magnetic resonance imaging reviewed from the recent neurologist consultation demonstrates no new lesions or tumor recurrence. There is evidence of post-treatment inflammation near the spinal cord, which may account for the patient's neurological symptoms. Nerve conduction studies have been ordered; results are pending.

Assessment and Plan:
The patient exhibits persistent neurological symptoms, including fatigue, digital paresthesia, and gait instability, likely attributable to post-treatment inflammatory changes near the spinal cord. There are no signs of disease progression and no additional chemotherapy or radiation therapy is indicated at this time. The plan includes referral to a physiotherapist with oncology experience for assistance with balance and mobility, close monitoring of neurological symptoms, and consideration of repeat imaging in six weeks if symptoms worsen. Steroid therapy is deferred unless there is escalation of symptoms. Neuropathic pain medications may be considered based on neurologist recommendations. The patient is instructed to maintain a symptom journal and a follow-up appointment is scheduled in four weeks.